BIOMAT Database Logo BIOMAT Database Logo

25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. 1968

J W Blunt, and H F DeLuca, and H K Schnoes

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002762 Cholecalciferol Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24. Vitamin D 3,(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol,Calciol,Cholecalciferols,Vitamin D3
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D006878 Hydroxides Inorganic compounds that contain the OH- group.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D012279 Rickets Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances. Rachitis,Rachitides
D013053 Spectrophotometry The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.
D013057 Spectrum Analysis The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Spectroscopy,Analysis, Spectrum,Spectrometry
D013261 Sterols Steroids with a hydroxyl group at C-3 and most of the skeleton of cholestane. Additional carbon atoms may be present in the side chain. (IUPAC Steroid Nomenclature, 1987) Sterol

Related Publications

J W Blunt, and H F DeLuca, and H K Schnoes
Synthesis of 25-hydroxycholecalciferol, the biologically effective metabolite of vitamin D.
May 1969, Steroids,
J W Blunt, and H F DeLuca, and H K Schnoes
Vitamin D3--biologically active metabolites.
July 1967, Nutrition reviews,
J W Blunt, and H F DeLuca, and H K Schnoes
Feedback regulation of 25-hydroxycholecalciferol metabolism by vitamin D3.
March 1975, Clinical science and molecular medicine,
J W Blunt, and H F DeLuca, and H K Schnoes
Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.
November 1966, Journal of lipid research,
J W Blunt, and H F DeLuca, and H K Schnoes
Specific nuclear uptake of 24,25-dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilage.
July 1980, FEBS letters,
J W Blunt, and H F DeLuca, and H K Schnoes
Placental transfer of vitamin D3 and 25-hydroxycholecalciferol in the rat.
June 1971, The Journal of laboratory and clinical medicine,
J W Blunt, and H F DeLuca, and H K Schnoes
A BIOLOGICALLY ACTIVE METABOLITE OF VITAMIN A AND VITAMIN A ACID.
July 1964, Nature,
J W Blunt, and H F DeLuca, and H K Schnoes
25-hydroxycholecalciferol. The probable metabolically active form of vitamin D3: its identification and subcellular site of action.
October 1969, Archives of internal medicine,
J W Blunt, and H F DeLuca, and H K Schnoes
Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.
April 1975, European journal of clinical pharmacology,
J W Blunt, and H F DeLuca, and H K Schnoes
Enhancement of chemical-carcinogen-induced cell transformation in hamster embryo cells by 1 alpha,25-dihydroxycholecalciferol, the biologically active metabolite of vitamin D3.
September 1984, Carcinogenesis,
Copied contents to your clipboard!